MedTrace Logo

Heart Rate Reducing Therapy in Cardiac CT Using Ivabradine and Bisoprolol

NCT02764970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2018-03-19

Study results available
· View outcomes & findings →

Summary

Out-patients scheduled for coronary computer tomographic angiography (CCTA) were screened regarding their baseline heart rate. If heart rate was \> 75, patients were pretreated with 10mg bisoprolol (group 1) or 10mg bisoprolol plus 7.5mg ivabradine (group 2) to reduce heart rate one our before CCTA was performed.

Heart rate, additional use of i.v. bradycardic agents, motion artefacts, radiation dose and drug tolerance was monitored.

Conditions

  • Bradycardia

Interventions

DRUG

Ivabradine 7.5mg orally

additive use to the standard medication with bisoprolol

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-09-30
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02764970 on ClinicalTrials.gov